CDKN2A and cancer: As a main limitation of this pan-cancer analysis, further wet lab validation is needed to elucidate the precise mechanisms underlying the CDKN2A gene’s role in cancer pathogenesis and its therapeutic implications since this analysis was carried out based on public computational databases.